NEOGENOMICS INC — Director's Dealing 2021

Dec 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-12-22

Reporting Person: Johnson Kevin C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-22	Common Stock	M	3334	$7.27	Acquired	37398	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-22	Stock Options (Right to Buy)	$7.27	M	3334	Disposed	2022-05-25	Common Stock (3334.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$22.52	2026-06-06	Common Stock (4269.0)	4269	Direct
Stock Options (Right to Buy)	$28.54	2027-05-28	Common Stock (3448.0)	3448	Direct
Stock Options (Right to Buy)	$40.9	2028-06-02	Common Stock (3714.0)	3714	Direct

Footnotes

F1: On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.